CCI approves acquisition of majority shareholding in Optimus Drugs by Sekhmet Pharmaventures Ruchika Sharma14 Aug 2022 11:00 AM ISTDeals beyond certain thresholds require approval from CCI, which keeps a tab on anti-competitive practices in the market place.
CDSCO panel rejects Optimus Pharma Phase III CT protocol of Tofacitinib Ointment for androgenic alopecia Dr. Divya Colin20 July 2022 6:00 PM ISTNew Delhi: Citing that there is no scientific rationality data and supportive published literature, the Subject Expert Committee (SEC) functional...
Hetero Labs, Optimus proposal to launch generic Paxlovid rejected by CDSCO panel: Report Dr. Divya Colin27 Jan 2022 6:10 PM ISTNew Delhi: In a major setback to Hetero Labs and Optimus Pharma, Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Health Bulletin 3/January/2022 Dr. Nandita Mohan3 Jan 2022 7:45 PM ISTHere are the Top Health stories of the dayIndia's Omicron count crosses 1,700-markNMC nod to DM cardiology course at PGIMS RohtakIn a major milestone...
13 pharma majors to launch anti-COVID drug Molnupiravir Medical Dialogues Team1 Jan 2022 7:36 PM ISTNew Delhi: Thirteen Indian pharmaceutical companies, including Torrent, Cipla, Sun Pharma, Dr Reddy's, Natco, Mylan, Hetero, Optimus will be...
Optimus Pharma seeks DCGI nod to produce generic version of Molnupiravir Ruchika Sharma30 Oct 2021 2:21 PM ISTOptimus' price of 40 cents per capsule is in line with market competition, said Reddy.
Optimus Pharma gets tentative USFDA approval for Brexpiprazole Tablets Medical Dialogues Team10 Oct 2021 10:15 AM ISTHyderabad: Optimus Pharma recently announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for the...
COVID: Optimus Pharma submits phase 3 trials interim result for Molnupiravir capsules Ruchika Sharma22 July 2021 2:00 PM ISTOptimus has approached DCGI to seek Emergency Use Authorization for Molnupiravir in India, the release said.
DCGI nod to Optimus Pharma Molnupiravir Phase 3 trials on COVID patients Ruchika Sharma20 May 2021 2:00 PM ISTHyderabad: Drugs Manufacturer from Hyderabad, Optimus Pharma on Wednesday said it has received Drugs Controller General of India (DCGI) nod for...
Optimus Pharma Anti-Parkinson's drug Safinamide gets DCGI okay Ruchika Sharma27 April 2021 12:10 PM ISTHyderabad: Optimus Pharma has announced that it has received DCGI approval for its Anti-Parkinson's drug Safinamide. Safinamide is indicated as...
